Provided by Tiger Fintech (Singapore) Pte. Ltd.

CH BIOTECH SER

0.810
+0.0101.25%
Volume:490.00K
Turnover:391.65K
Market Cap:790.34M
PE:-3.96
High:0.810
Open:0.800
Low:0.780
Close:0.800
Loading ...

China Biotech Services Holdings Ltd. Conducted Annual General Meeting

Reuters
·
Yesterday

BRIEF-China Biotech Services Signs Memorandum Of Understanding With Stella Pharma Corporation

Reuters
·
08 May

China Biotech Services - Memorandum of Understanding Signed With Stella Pharma Corporation for Sales and Production of Steboronine

THOMSON REUTERS
·
08 May

China Biotech Services - Bank of Shanghai, Pudong Branch to Provide Credit Line in Principal Amount of up to RMB4 Mln to Shanghai Longyao

THOMSON REUTERS
·
24 Apr

China Biotech Services Holdings Full Year 2024 Earnings: HK$0.20 loss per share (vs HK$0.099 loss in FY 2023)

Simply Wall St.
·
31 Mar

BRIEF-China Biotech Services Sees FY Net Loss Attributable Of HK$180 Million

Reuters
·
03 Mar

China Biotech Services - Expected Result Due to Reduction in Revenue From Diminished Demand for Covid-19 Nucleric Acid Test, Others

THOMSON REUTERS
·
03 Mar

China Biotech Services Sees Net Loss Attributable of HK$180 Mln for FY2024

THOMSON REUTERS
·
03 Mar

Selling HK$5.0m Of China Biotech Services Holdings Stock Rewarded Insiders

Simply Wall St.
·
03 Mar

BRIEF-China Biotech Services Says Registered Capital Of Pengbo (Hainan) To Increase To RMB166.7 Mln

Reuters
·
27 Feb

China Biotech Services - Registered Capital of Pengbo (Hainan) to Increase to RMB166.7 Mln

THOMSON REUTERS
·
27 Feb

China Biotech Services - Strategic Cooperation Framework Agreement With Shenzhen Bgi Technology

THOMSON REUTERS
·
25 Feb

China Biotech Services - Investment Involves Injecting RMB20 Mln to RMB30 Mln to Subscribe for Newly Issued Registered Capital of Pengbo (Hainan)

THOMSON REUTERS
·
25 Feb

China Biotech Services - Letter of Intent on Investment in Pengbo (Hainan) Medical Technology

THOMSON REUTERS
·
25 Feb

China Biotech Services - Under Framework Agreement Parties to Jointly Conduct Academic Research on Novel Cd20-Targeted CAR-T Therapy, Others

THOMSON REUTERS
·
25 Feb

Further weakness as China Biotech Services Holdings (HKG:8037) drops 11% this week, taking five-year losses to 63%

Simply Wall St.
·
09 Jan

BRIEF-China Biotech Services Announces Issue Of Convertible Bonds Of $6 Mln

Reuters
·
17 Dec 2024

China Biotech Services Holdings Ltd - Issue of Convertible Bonds of US$6 Mln

THOMSON REUTERS
·
17 Dec 2024